Other Operating Results
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Billions of yen
|
|
|
% Change
|
|
|
For the nine months ended
|
|
|
(B-A)/(A)
|
|
|
December 31,
2020 (A)
|
|
|
December 31,
2021 (B)
|
|
Net revenue
|
|
|
151.7
|
|
|
|
115.0
|
|
|
|
(24.2
|
)
|
Non-interest expenses
|
|
|
114.0
|
|
|
|
114.2
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
37.7
|
|
|
|
0.9
|
|
|
|
(97.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenue was 115.0 billion yen including income of 36.2 billion yen recognized in
June 2021 from the sale of a part of our shares held in Nomura Research Institute, Ltd. Income before income taxes was 0.9 billion yen, as a result of recognizing expenses of about 40 billion yen related to legacy transactions.
(2)
|
Consolidated Financial Position
|
Total assets as of December 31, 2021 were 45,215.4 billion yen, an increase of 2,698.9 billion yen compared to
March 31, 2021, mainly due to the increase in Securities purchased under agreements to resell and Trading assets. Total liabilities as of December 31, 2021 were 42,336.1 billion yen, an increase of 2,576.1 billion
yen compared to March 31, 2021, mainly due to the increase in Securities sold under agreements to repurchase and Trading liabilities. Total equity as of December 31, 2021 was 2,879.2 billion yen, an increase of
122.8 billion yen compared to March 31, 2021.
(3)
|
Consolidated Earnings Forecasts
|
Nomura provides investment, financing and related services in the capital markets on a global basis. In the global capital
markets there exist uncertainties due to, but not limited to, economic and market conditions. Nomura, therefore, does not present earnings and dividend forecasts.
(4)
|
Risks related to the COVID-19 pandemic
|
The COVID-19 pandemic has affected Nomuras business, and this may continue in the future.
Various risks recognized related to the COVID-19 pandemic is disclosed in Risk Factors
in Nomura Holdings, Inc.s Annual Securities Report (the annual report filed in Japan on June 25, 2021) and Item 3. D. Risk Factors. in Form 20-F (the annual report filed with the U.S. Securities and
Exchange Commission on June 25, 2021) for the year ended March 31, 2021.
4